Purchase Order 75N98026P00592
Award Date 5/26/26
Potential Completion Date 9/30/26
Potential Value $110K
Funding Federal Agency
Contracting Federal Agency
Ultimate Awardee
Not listed NAICS Category
PSC Category
Set-Aside Type
No Set-Aside Used
Federal Contract Vehicle
- Not listed
Extent Competed
Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Bethesda, MD 20892, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a $100,000.00 firm-fixed-price purchase order contract awarded by the National Institutes of Health (NIH) Clinical Center to Quva Pharma, Inc., a for-profit organization located in Sugar Land, Texas. The contract is for the delivery of specialized sterile compounded pharmaceutical products, including patient-controlled analgesia systems, epidural products, and other critical medical preparations to support the NIH Clinical Center's pain management initiatives and clinical research needs....
- This is a firm fixed price delivery order awarded by the Department of Health and Human Services' National Institutes of Health Clinical Center to Quva Pharma, Inc., a 503B outsourcing facility that provides sterile compounded pharmaceutical products to federal agencies. The contract is for outsourcing patient-controlled analgesia systems (PCACs) and epidurals, with a potential value of $250,000.00 and a completion date of September 30, 2024. Quva Pharma has previously held prime federal...
- <p>The NIH Clinical Center issued a $50,000 delivery order to Central Admixture Pharmacy Services, Inc. on January 1, 2020, for 503B compounded pharmaceutical products as needed from its central admixture pharmacy services.</p> <p>Place of performance is Irvine, CA. The order carries a firm fixed price and ultimate completion date of September 30, 2020. No set-aside was used.</p>
- This is a $231,100.12 firm fixed price purchase order contract awarded by the Department of the Army Medical Command to Quva Pharma, Inc., a for-profit 503B outsourcing facility that provides sterile compounded pharmaceutical products. The contract is set aside for small businesses and covers the delivery of compounded pharmaceuticals to support the Army's medical operations. Quva Pharma has previously held other federal contracts to provide sterile compounding services, patient-controlled...
- <p>The NIH Clinical Center issued a delivery order to Amerisourcebergen Drug Corp on January 30, 2013, with a ceiling value of $55,928.82 for pharmaceutical supply.</p> <p>Place of performance is Glen Allen, VA. The order was priced on a firm fixed-price basis and reached final close on February 28, 2013.</p>
- <p>The NIH Clinical Center issued a delivery order to Amerisourcebergen Drug Corp on May 6, 2013, with a ceiling value of $87,645.15 for pharmaceutical supplies.</p> <p>Place of performance is Glen Allen, VA. The order is firm fixed price and reached final close on June 2, 2013. No set-aside was used.</p>
- <p>The National Institutes of Health Clinical Center issued a delivery order to AmerisourceBergen Drug Corp on February 20, 2013, with a ceiling value of $56,084.06 for pharmaceutical supply.</p> <p>Place of performance is Glen Allen, VA. The order was firm fixed price with an ultimate completion date of March 21, 2013.</p>
- <p>The National Institutes of Health Clinical Center issued a delivery order to Amerisourcebergen Drug Corp on November 21, 2012, with a ceiling value of $83,060.75 for pharmaceutical supply.</p> <p>Place of performance is Glen Allen, VA. The order was firm fixed price with an ultimate completion date of December 20, 2012. No set-aside was used.</p>
- The NIH Clinical Center awarded a purchase order to GLC On-The-Go, Inc., a Woman-Owned Small Business, on May 17, 2018, with a ceiling value of $116,576.25 under a firm fixed-price arrangement. Performance is located in Bethesda, Maryland. The purchase order was issued as part of the FY26 UDO initiative to de-obligate unexpended and expiring fiscal year 2021 funding in accordance with 31 U.S.C. Section 1552(a) in preparation for the September 30, 2026 closing of the period of availability. The...
- <p>The Defense Logistics Agency issued a delivery order to AmerisourceBergen Drug Corp on February 11, 2026, for Quviviq 50 mg tablets (30 count) with a ceiling value of $1,233.40.</p> <p>Place of performance is Conshohocken, PA. The ultimate completion date is February 12, 2026. The order is priced on a firm fixed-price basis under a non-competed awards program.</p>